Timothy Horwedel

Board-certified, trained and experienced transplant pharmacist based out of St. Louis. Depth of experience is in liver and kidney transplant with emphasis on infectious diseases after transplant including urinary tract infections, hepatitis B and C, and opportunistic infections.

Education:
PharmD, 2008: Northeastern University, Boston, MA

Training:
PGY1 Pharmacy Residency: Henry Ford Hospital, Detroit, MI
PGY2 Transplant Residency: Barnes-Jewish Hospital, St. Louis, MO

Certification: Board Certified Pharmacotherapy Specialist

Experience:
1/2012 - Current: Liver, Kidney and Pancreas Transplant Clinical Specialist, Barnes-Jewish Hospital, St. Louis, MO
1/2012 - Current: Clinical Lecturer, Adjunct Clinical Assistant Professor
8/2009 - 1/2012: Liver, Kidney and Pancreas Transplant Clinical Specialist, Clinical Assistant Professor, University of Michigan, Ann Arbor, MI
7/2008 - Current - Pharmacist - Target Pharmacy

Have given talks on the following topics to fellow medical professionals:
Nulojix (Belatacept)
Zortress (Everolimus)
Incivek (Teleprevir)
Post-transplant sepsis in kidney recipients
Drug interactions with transplant immunosuppression
Patient advocacy after transplant
Pharmacodynamic monitoring of liver transplant recipients
Post-transplant hepatitis C recurrence
Use of Nabi-HB after HepBcAb(+) liver transplantation

I am happy to develop talks in other affiliated areas as requested.